GALILEO GENOMICS INC.

13.12.2004 – 14:29
Galileo Genomics Raises CDN$11M in Equity Financing; Changes Name to Genizon BioSciences to Reflect Addition of Genes-to-Targets Capability
Montreal, Canada (ots/PRNewswire) - Galileo Genomics Inc., a Montreal-based gene and drug target discovery company, announced today it raised CDN$11.1 million in additional equity funding to close the 2nd tranche of its Series B financing. This round, originally targeted at CDN$10 million, is the latest in a ...
mehr
26.10.2004 – 13:43
Galileo Genomics Unveils an 80,700 SNP Quebec Linkage Disequilibrium Map for use in Genome-Wide Association Studies
Montreal, Canada (ots/PRNewswire) - Galileo Genomics announced today the completion of a panel of approximately 80,700 SNP markers covering 99.8% of the sequenced genome at a density optimised for the Quebec French Canadian Founder Population (QFP). This panel, known as the Quebec Linkage Disequilibrium Map ...
mehr